Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | ESR2 | Q92731 | 10/20 | 0.46 |
| ▸ | ESR1 | P03372 | 9/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.43 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.43 |
| ▸ | ABL1 | P00519 | 1/20 | 0.43 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.43 |
| ▸ | BCR | P11274 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.42 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29624584 | 1.00 | CYP1A2 (0.50) | CYP1A2ESR2ESR1CYP3A4ALOX15 | |
| SCHEMBL1478481 | 0.85 | CYP1A1 (0.54) | CYP1A2CYP1A1CYP1B1 | |
| SCHEMBL29870412 | 0.85 | CYP1A1 (0.54) | CYP1A2CYP1A1CYP1B1 | |
| SCHEMBL10481157 | 0.83 | CYP1A1 (0.52) | CYP1A1CYP1B1 | |
| SCHEMBL21741209 | 0.81 | CYP1A2 (0.54) | CYP1A2ESR2ESR1CYP3A4ALOX15 | |
| SCHEMBL29203830 | 0.80 | CYP1A1 (0.50) | CYP3A4ALOX15HIF1AHSD17B10TDP1 | |
| SCHEMBL21967023 | 0.79 | CYP1A2 (0.52) | CYP1A2ESR2ESR1CYP3A4ALOX15 | |
| SCHEMBL12986899 | 0.78 | CYP1A1 (0.52) | CYP1A2CYP1A1CYP1B1 | |
| SCHEMBL29832259 | 0.78 | CYP1A1 (0.52) | CYP1A2CYP1A1CYP1B1 | |
| SCHEMBL31453310 | 0.77 | CA2 (0.58) | CYP1A2ESR2ESR1CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3632983-B1 | POLYCARBONATE RESIN COMPOSITION, MOLDED ARTICLE, POLYCARBONATE RESIN, AND TERMINAL-BLOCKING AGENT FOR POLYCARBONATE RESIN | MITSUBISHI GAS CHEMICAL CO (JP) | 2022-08-10 | — | — | EP | disclosed |
| US-11370883-B2 | Polycarbonate resin composition, molded article, polycarbonate resin, and end-capping agent for polycarbonate resin | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2022-06-28 | — | — | US | disclosed |
| US-11370883-B2 | Polycarbonate resin composition, molded article, polycarbonate resin, and end-capping agent for polycarbonate resin | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2022-06-28 | — | — | US | disclosed |
| CN-110709469-B | Polycarbonate resin composition, molded article, polycarbonate resin, and end-capping agent for polycarbonate resin | 三菱瓦斯化学株式会社 | 2022-04-29 | — | — | CN | disclosed |
| US-20210355409-A1 | PHOTOLUMINESCENT LUBRICATING GREASE COMPOSITION, PHOTOLUMINESCENT MATERIAL AND THE PREPARATION METHODS THEREOF | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2021-11-18 | — | — | US | disclosed |
| US-20200115496-A1 | POLYCARBONATE RESIN COMPOSITION, MOLDED ARTICLE, POLYCARBONATE RESIN, AND END-CAPPING AGENT FOR POLYCARBONATE RESIN | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2020-04-16 | — | — | US | disclosed |
| EP-3632983-A1 | POLYCARBONATE RESIN COMPOSITION, MOLDED ARTICLE, POLYCARBONATE RESIN, AND TERMINAL-BLOCKING AGENT FOR POLYCARBONATE RESIN | Mitsubishi Gas Chemical Company, Inc. (JP) | 2020-04-08 | — | — | EP | disclosed |
| CN-110709469-A | Polycarbonate resin composition, molded article, polycarbonate resin, and end-capping agent for polycarbonate resin | 三菱瓦斯化学株式会社 | 2020-01-17 | — | — | CN | disclosed |
| EP-2373163-B1 | HETEROCYCLIC COMPOUNDS AND METHODS OF USE | GENENTECH INC (US) | 2015-06-10 | — | — | EP | disclosed |
| EP-2373163-B1 | HETEROCYCLIC COMPOUNDS AND METHODS OF USE | GENENTECH INC (US) | 2015-06-10 | — | — | EP | disclosed |
| US-20100210622-A1 | HETEROCYCLIC COMPOUNDS AND METHODS OF USE | ABBVIE INC. | 2010-08-19 | — | — | US | disclosed |
| WO-2010080503-A1 | HETEROCYCLIC COMPOUNDS AND METHODS OF USE | GENENTECH, INC. (US) | 2010-07-15 | — | — | WO | disclosed |
| WO-2010080503-A1 | HETEROCYCLIC COMPOUNDS AND METHODS OF USE | GENENTECH, INC. (US) | 2010-07-15 | — | — | WO | disclosed |
| US-20030065117-A1 | Modified silicone compound, process of producing the same, and cured object obtained therefrom | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2003-04-03 | — | — | US | disclosed |
| EP-0793656-B1 | NOVEL BENZYL PYRIMIDINES | BASILEA PHARMACEUTICA AG (CH) | 2003-03-26 | — | — | EP | disclosed |
| EP-0834499-B1 | Process for the preparation of aromatic vinyl compounds | DAINIPPON INK & CHEMICALS (JP) | 2001-07-25 | — | — | EP | disclosed |
| US-5763450-A | BACTERICIDES; TREATMENT OF INFECTIOUS DISEASES | HOFFMANN-LA ROCHE INC. (US) | 1998-06-09 | — | — | US | disclosed |
| EP-0834499-A1 | Process for the preparation of aromatic vinyl compounds | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1998-04-08 | — | — | EP | disclosed |
| EP-0793656-A1 | NOVEL BENZYL PYRIMIDINES | F. HOFFMANN-LA ROCHE AG (CH) | 1997-09-10 | — | — | EP | disclosed |
| WO-1996016046-A2 | NOVEL BENZYL PYRIMIDINES | F. HOFFMANN-LA ROCHE AG (CH) | 1996-05-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200115496-A1 | POLYCARBONATE RESIN COMPOSITION, MOLDED ARTICLE, POLYCARBONATE RESIN, AND END-CAPPING AGENT FOR POLYCARBONATE RESIN | CAPZA1, RNGTT, RPP30 | CYP1A2 4125/4885ESR2 2299/4885ESR1 2484/4885 |
| US-20100210622-A1 | HETEROCYCLIC COMPOUNDS AND METHODS OF USE | BCL2A1, BAX, BCL2 | CYP1A2 360/4885ESR2 260/4885ESR1 415/4885 |
| US-20210355409-A1 | PHOTOLUMINESCENT LUBRICATING GREASE COMPOSITION, PHOTOLUMINESCENT MATERIAL AND THE PREPARATION METHODS THEREOF | TPSD1, TPSG1, TPSB2 | CYP1A2 1616/4885ESR2 663/4885ESR1 879/4885 |
| US-11370883-B2 | Polycarbonate resin composition, molded article, polycarbonate resin, and end-capping agent for polycarbonate resin | CAPZA1, RNGTT, RPP30 | CYP1A2 4125/4885ESR2 2299/4885ESR1 2484/4885 |
| US-20030065117-A1 | Modified silicone compound, process of producing the same, and cured object obtained therefrom | ORMDL3, SGMS1, HEATR1 | CYP1A2 3650/4885ESR2 961/4885ESR1 758/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.